A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trials
用户wxb8loTerxGI
1个月前
72
10
已完结
1. 系统已在2026-06-12 10:59:09对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.atherosclerosis.2026.120742
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0021915026001085
其他信息:
出版社: Elsevier BV
作者: Patrick Nolain; Magnus Fugger; Bibi Toft Hellinghus; Ingo Hilgendorf; Jesper Falkesgaard Højen; Peter Libby; Giovanna Liuzzo; Christian M. Matter; Katherine R. Tuttle; Paul M Ridker
